JP2023542500A5 - - Google Patents
Info
- Publication number
- JP2023542500A5 JP2023542500A5 JP2023516250A JP2023516250A JP2023542500A5 JP 2023542500 A5 JP2023542500 A5 JP 2023542500A5 JP 2023516250 A JP2023516250 A JP 2023516250A JP 2023516250 A JP2023516250 A JP 2023516250A JP 2023542500 A5 JP2023542500 A5 JP 2023542500A5
- Authority
- JP
- Japan
- Prior art keywords
- saponin
- xyl
- rha
- fuc
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL2026442 | 2020-09-10 | ||
| NL2026442 | 2020-09-10 | ||
| NL2027405A NL2027405B1 (en) | 2021-01-26 | 2021-01-26 | Semicarbazone-based saponin conjugate |
| NL2027405 | 2021-01-26 | ||
| PCT/NL2021/050384 WO2021261992A1 (en) | 2020-06-24 | 2021-06-18 | Conjugate of galnac and saponin, therapeutic composition comprising said conjugate and a galnac-oligonucleotide conjugate |
| NLPCT/NL2021/050384 | 2021-06-18 | ||
| PCT/NL2021/050549 WO2022055351A1 (en) | 2020-09-10 | 2021-09-09 | Conjugate of saponin, oligonucleotide and galnac |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023542500A JP2023542500A (ja) | 2023-10-10 |
| JP2023542500A5 true JP2023542500A5 (cg-RX-API-DMAC10.html) | 2024-09-02 |
Family
ID=99799161
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023516250A Pending JP2023542500A (ja) | 2020-09-10 | 2021-09-09 | サポニン、オリゴヌクレオチド、及びgalnacのコンジュゲート |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240327829A1 (cg-RX-API-DMAC10.html) |
| EP (2) | EP4210760B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2023542500A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20230066384A (cg-RX-API-DMAC10.html) |
| CN (1) | CN116437965A (cg-RX-API-DMAC10.html) |
| IL (1) | IL301214A (cg-RX-API-DMAC10.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117244054B (zh) * | 2023-10-16 | 2024-06-07 | 国药中生生物技术研究院有限公司 | 具有螺甾烷-O-gal结构的化合物的佐剂用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2395818T3 (es) * | 2004-07-13 | 2013-02-15 | Charite - Universitatsmedizin Berlin | Composición que comprende un agente farmacológicamente activo acoplado a un componente específico de célula diana, y una saponina |
| WO2011054811A1 (en) * | 2009-11-03 | 2011-05-12 | Santaris Pharma A/S | Rna antagonists targeting hsp27 combination therapy |
| KR20160083876A (ko) * | 2013-11-14 | 2016-07-12 | 로슈 이노베이션 센터 코펜하겐 에이/에스 | ApoB 안티센스 접합체 화합물 |
| US20220023433A1 (en) * | 2018-12-21 | 2022-01-27 | Sapreme Technologies B.V. | Saponin Conjugates |
-
2021
- 2021-09-09 US US18/044,945 patent/US20240327829A1/en active Pending
- 2021-09-09 JP JP2023516250A patent/JP2023542500A/ja active Pending
- 2021-09-09 EP EP21794416.4A patent/EP4210760B1/en active Active
- 2021-09-09 IL IL301214A patent/IL301214A/en unknown
- 2021-09-09 CN CN202180070494.9A patent/CN116437965A/zh active Pending
- 2021-09-09 KR KR1020237011435A patent/KR20230066384A/ko active Pending
- 2021-09-09 EP EP25151594.6A patent/EP4529953A3/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023532040A5 (cg-RX-API-DMAC10.html) | ||
| US20240307545A1 (en) | Conjugate of saponin, oligonucleotide and galnac | |
| EP3978609A1 (en) | Nucleic acid, pharmaceutical composition, conjugate, preparation method, and use | |
| US20070060499A1 (en) | Chloroquine combination drugs and methods for their synthesis | |
| EP3992290A1 (en) | Nucleic acid, pharmaceutical composition and conjugate, preparation method therefor and use thereof | |
| JP2025041739A (ja) | 核酸、薬物組成物及び複合体ならびに調製方法と使用 | |
| CN110997919A (zh) | 双链寡核苷酸、含双链寡核苷酸的组合物与缀合物及制备方法和用途 | |
| KR20230043114A (ko) | Galnac과 사포닌의 접합체, 상기 접합체 및 galnac-올리고뉴클레오티드 접합체를 포함하는 치료적 조성물 | |
| JP2024530839A5 (cg-RX-API-DMAC10.html) | ||
| US11485752B2 (en) | Modified oligonucleotides and compound that can be used for synthesizing same | |
| US20230277612A1 (en) | Saponin derivatives for use in medicine | |
| EP4635501A2 (en) | Saponin derivatives with improved therapeutic window | |
| JP2022542075A5 (cg-RX-API-DMAC10.html) | ||
| CA3183881A1 (en) | Therapeutic combination of galnac-oligonucleotide conjugate and saponin, and uses thereof | |
| WO2023208109A1 (zh) | 用于抑制HSD17B13表达的siRNA、其缀合物和药物组合物及其用途 | |
| US20060040879A1 (en) | Chloroquine coupled nucleic acids and methods for their synthesis | |
| JP2023533693A5 (cg-RX-API-DMAC10.html) | ||
| US20250320500A1 (en) | Nucleic acid, pharmaceutical composition and sirna conjugate containing the nucleic acid, preparation method therefor, and use thereof | |
| EP4171643B1 (en) | Therapeutic combination of galnac-oligonucleotide conjugate and saponin, and uses thereof | |
| EP4210760B1 (en) | Conjugate of saponin, oligonucleotide and galnac | |
| CN104087574B (zh) | 一种用于制备肝细胞靶向转递小干扰rna的方法 | |
| HK40128805A (en) | Therapeutic combination of galnac-oligonucleotide conjugate and saponin, and uses thereof | |
| HK40110483A (en) | Conjugate of saponin, oligonucleotide and galnac | |
| JP2025514180A5 (cg-RX-API-DMAC10.html) | ||
| HK40129944A (zh) | Galnac和皂苷的缀合物、包含所述缀合物和galnac-寡核苷酸缀合物的治疗性组合物 |